interaction records 54 assistance programs 55 0 personal data stored
OmniRx › Tools › Drug shortage outlook › Conivaptan Hydrochloride

Shortage outlook · all drugs · read October 2026

How long has Conivaptan Hydrochloride been on the FDA shortage list?

Conivaptan Hydrochloride has been on the FDA shortage list for 2 years and 8 months. 132 of the 397 listings measured since 2014 lasted at least that long. Of the 132 past listings that reached the same age, 88% were still listed 6 months later (102 listings measured), 81% were still listed 12 months later (87 listings measured) and 62% were still listed 24 months later (58 listings measured). These are counts of listings, not a forecast.

Compiled by Vincent Wesley Couey (ORCID 0009-0005-6869-308X). FDA list read October 2026.

Not medical advice. A listing is what the FDA published, not a measure of what your pharmacy can supply. Do not use this page to decide whether to start, stop or change a medicine. Ask your pharmacist or prescriber, and see FDA drug shortage information for current notices.
Conivaptan Hydrochlorideon the FDA shortage list now
32months listed

Conivaptan Hydrochloride has been on the FDA shortage list for 2 years and 8 months (March 2024 to October 2026).

  1. 132 of the 397 listings measured since 2014 lasted at least that long.
  2. Of the 132 past listings that reached the same age, 88% were still listed 6 months later (102 listings measured), 81% were still listed 12 months later (87 listings measured) and 62% were still listed 24 months later (58 listings measured).
  3. Conivaptan Hydrochloride has been listed 2 times since 2014: earlier listings lasted 1 year and 10 months.
  4. None of this predicts an end date. A listing ends when the FDA removes it, which reflects supply across the whole country, and says nothing about one pharmacy's shelf.

The listing history, to scale

  1. Conivaptan Hydrochloride InjectionListed April 2022 to January 2024 · 1 year and 10 months
  2. Conivaptan Hydrochloride InjectionListed since March 2024 · 2 years and 8 months

What past listings of this age did

Of past listings that had already run 2 years and 8 months, how many were still listed later?

After 6 more months88%102 listings measured
After 12 more months81%87 listings measured
After 24 more months62%58 listings measured

What the FDA list says about it today

1presentations listed
1company
14 March 2022first posted

Reasons companies gave: delay in shipping of the drug (1). FDA category: Cardiovascular.

Company by company

Of 1 presentations, the companies reported 0 available, 0 with limited availability and 1 unavailable. This is each company's own report to the FDA, with the date of its last update.

FDA shortage list read October 2026 (monthly archived copies since 2014, rebuilt in the published dataset; current listing file read 11 November 2026). Listing is the FDA's status, not a statement about any pharmacy.

Where can you go from this result?

This result is one of 61 drugs on the list now. Open it in the lookup to search another drug, or read how the listings were measured.

To check what is available now, ask your pharmacist, and see FDA drug shortage information and the FDA drug shortages database.